h377ticw | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/h377ticw_hasAnnotation_C1428785> <https://research.tib.eu/covid-19/entity/h377ticw_hasAnnotation_C1999216> <https://research.tib.eu/covid-19/entity/h377ticw_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Hong%2C_Kyung_Soo%3B_Ahn%2C_June_Hong%3B_Jang%2C_Jong_Geol%3B_Lee%2C_Jong_Ho%3B_Kim%2C_Hong_Nam%3B_Kim%2C_Dongha%3B_Lee%2C_Wonhwa>
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41392-020-00391-5>
?:doi	10.1038/s41392-020-00391-5
?:journal	Signal_Transduct_Target_Ther
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/b1d47cac9b7bb5b768ae6b4259bc57a583b3f248.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7670835>
?:pmid	<https://research.tib.eu/covid-19/entity/33203839.0>
?:pmid	33203839.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/b1d47cac9b7bb5b768ae6b4259bc57a583b3f248>
?:source	Medline; PMC
?:title	GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-17

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/h377ticw>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/h377ticw>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all